Halozyme Therapeutics shares owned by Oak Hill Wealth Advisors
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Oak Hill Wealth Advisors
from 13F filings
Historical chart of Oak Hill Wealth Advisors investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Oak Hill Wealth Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Oak Hill Wealth Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $785k | 11k | 73.34 |
| 2025-06-30 | $597k | 11k | 55.80 |
| 2025-03-31 | $683k | 11k | 63.81 |
| 2024-12-31 | $516k | 11k | 47.81 |
| 2024-09-30 | $618k | 11k | 57.24 |
| 2024-06-30 | $566k | 11k | 52.36 |
| 2024-03-31 | $460k | 11k | 40.68 |
| 2023-12-31 | $462k | 13k | 36.96 |
| 2023-09-30 | $478k | 13k | 38.20 |
| 2023-06-30 | $451k | 13k | 36.07 |
| 2023-03-31 | $477k | 13k | 38.19 |
| 2022-12-31 | $711k | 13k | 56.90 |